Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.


Journal

Translational research : the journal of laboratory and clinical medicine
ISSN: 1878-1810
Titre abrégé: Transl Res
Pays: United States
ID NLM: 101280339

Informations de publication

Date de publication:
02 2021
Historique:
received: 27 04 2020
revised: 29 07 2020
accepted: 04 08 2020
pubmed: 12 8 2020
medline: 20 2 2021
entrez: 12 8 2020
Statut: ppublish

Résumé

Neurofibromatosis type 1 (NF1) is a heritable cancer predisposition syndrome resulting from mutations in the NF1 tumor suppressor gene. Genotype-phenotype correlations for NF1 are rare due to the large number of NF1 mutations and role of modifier genes in manifestations of NF1; however, emerging reports suggest that persons with NF1 display a distinct anthropometric and metabolic phenotype featuring short stature, low body mass index, increased insulin sensitivity, and protection from diabetes. Nf1 heterozygous (Nf1+/-) mice accurately reflect the dominant inheritance of NF1 and are regularly employed as a model of NF1. Here, we sought to identify whether Nf1+/- mice recapitulate the anthropometric and metabolic features identified in persons with NF1. Littermate 16-20 week-old male wildtype (WT) and Nf1+/- C57B/6J mice underwent nuclear magnetic resonance (NMR), indirect calorimetry, and glucose/insulin/pyruvate tolerance testing. In some experiments, tissues were harvested for NMR and histologic characterization. Nf1+/- mice are leaner with significantly reduced visceral and subcutaneous fat mass, which corresponds with an increased density of small adipocytes and reduced leptin levels. Additionally, Nf1+/- mice are highly reliant on carbohydrates as an energy substrate and display increased glucose clearance and insulin sensitivity, but normal response to pyruvate suggesting enhanced glucose utilization and preserved gluconeogenesis. Finally, WT and Nf1+/- mice subjected to high glucose diet were protected from diet-induced obesity and hyperglycemia. Our data suggest that Nf1+/- mice closely recapitulate the anthropometric and metabolic phenotype identified in persons with NF1, which will impact the interpretation of previous and future translational studies of NF1.

Identifiants

pubmed: 32781282
pii: S1931-5244(20)30197-3
doi: 10.1016/j.trsl.2020.08.001
pmc: PMC7779711
mid: NIHMS1620127
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

52-63

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL130301
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL126949
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL147639
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL142097
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL147159
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL139562
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY029318
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Rebekah Tritz (R)

Vascular Biology Center, Augusta University, Augusta, Georgia; Department of Pediatrics, Medical College of Georgia, Augusta University, Augusta, Georgia.

Tyler Benson (T)

Vascular Biology Center, Augusta University, Augusta, Georgia.

Valerie Harris (V)

Vascular Biology Center, Augusta University, Augusta, Georgia; Department of Pediatrics, Medical College of Georgia, Augusta University, Augusta, Georgia.

Farlyn Z Hudson (FZ)

Vascular Biology Center, Augusta University, Augusta, Georgia; Department of Pediatrics, Medical College of Georgia, Augusta University, Augusta, Georgia.

James Mintz (J)

Vascular Biology Center, Augusta University, Augusta, Georgia.

Hanfang Zhang (H)

Vascular Biology Center, Augusta University, Augusta, Georgia; Department of Pediatrics, Medical College of Georgia, Augusta University, Augusta, Georgia.

Simone Kennard (S)

Vascular Biology Center, Augusta University, Augusta, Georgia.

Weiqin Chen (W)

Vascular Biology Center, Augusta University, Augusta, Georgia.

David W Stepp (DW)

Vascular Biology Center, Augusta University, Augusta, Georgia; Department of Physiology, Medical College of Georgia, Augusta University, Augusta, Georgia.

Gabor Csanyi (G)

Vascular Biology Center, Augusta University, Augusta, Georgia; Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, Augusta, Georgia.

Eric J Belin de Chantemèle (EJ)

Vascular Biology Center, Augusta University, Augusta, Georgia; Department of Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia.

Neal L Weintraub (NL)

Vascular Biology Center, Augusta University, Augusta, Georgia; Department of Medicine, Medical College of Georgia, Augusta University, Augusta, Georgia.

Brian K Stansfield (BK)

Vascular Biology Center, Augusta University, Augusta, Georgia; Department of Pediatrics, Medical College of Georgia, Augusta University, Augusta, Georgia. Electronic address: bstansfield@augusta.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH